Concepedia

Emily K. Kleczko

EK

16

Publications

799

Citations

14

H-Index

2013

Active since

Affiliations

University of Colorado Anschutz Medical Campus(Current)

VA Eastern Colorado Health Care System

University of Colorado Denver

University Hospital Bonn

Hypertension Institute

Emily K. Kleczko is an author at University of Colorado Anschutz Medical Campus specializing in medicine, immunology, and urology.

ORCID

Top concepts

Publications per year

2013–2023

16

Publications

16

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 255 citations · Full text

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

Friederike Göke, Alina Franzen, Trista K. Hinz et al. · Clinical Cancer Research · 2015 · 84 citations · Full text

CD8+ T cells modulate autosomal dominant polycystic kidney disease progression

Emily K. Kleczko, Kenneth H. Marsh, Logan C. Tyler et al. · Kidney International · 2018 · 69 citations · Full text

, , +13

Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC

Katherine R. Singleton, Trista K. Hinz, Emily K. Kleczko et al. · Cancer Research · 2015 · 63 citations · Full text

Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms

Alexander Neuwelt, Abigail K. Kimball, Amber M. Johnson et al. · Journal for ImmunoTherapy of Cancer · 2020 · 50 citations · Full text

Rows per page

1–5 of 16